581 related articles for article (PubMed ID: 27236439)
1. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.
Kimura M; Naito T; Kenmotsu H; Taira T; Wakuda K; Oyakawa T; Hisamatsu Y; Tokito T; Imai H; Akamatsu H; Ono A; Kaira K; Murakami H; Endo M; Mori K; Takahashi T; Yamamoto N
Support Care Cancer; 2015 Jun; 23(6):1699-708. PubMed ID: 25430482
[TBL] [Abstract][Full Text] [Related]
4. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer.
Stene GB; Helbostad JL; Amundsen T; Sørhaug S; Hjelde H; Kaasa S; Grønberg BH
Acta Oncol; 2015 Mar; 54(3):340-8. PubMed ID: 25225010
[TBL] [Abstract][Full Text] [Related]
5. The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer.
Kim EY; Kim YS; Seo JY; Park I; Ahn HK; Jeong YM; Kim JH; Kim N
PLoS One; 2016; 11(8):e0161125. PubMed ID: 27537502
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer.
Kim EY; Lee HY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM; Kim JH
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28426181
[TBL] [Abstract][Full Text] [Related]
8. Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors.
Roch B; Coffy A; Jean-Baptiste S; Palaysi E; Daures JP; Pujol JL; Bommart S
Lung Cancer; 2020 May; 143():19-26. PubMed ID: 32200137
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
[TBL] [Abstract][Full Text] [Related]
10. Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?
Rossi S; Di Noia V; Tonetti L; Strippoli A; Basso M; Schinzari G; Cassano A; Leone A; Barone C; D'Argento E
Future Oncol; 2018 Apr; 14(10):919-926. PubMed ID: 29528255
[TBL] [Abstract][Full Text] [Related]
11. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
Baracos VE; Reiman T; Mourtzakis M; Gioulbasanis I; Antoun S
Am J Clin Nutr; 2010 Apr; 91(4):1133S-1137S. PubMed ID: 20164322
[TBL] [Abstract][Full Text] [Related]
12. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study.
Naito T; Okayama T; Aoyama T; Ohashi T; Masuda Y; Kimura M; Shiozaki H; Murakami H; Kenmotsu H; Taira T; Ono A; Wakuda K; Imai H; Oyakawa T; Ishii T; Omori S; Nakashima K; Endo M; Omae K; Mori K; Yamamoto N; Tanuma A; Takahashi T
BMC Cancer; 2017 Nov; 17(1):800. PubMed ID: 29183277
[TBL] [Abstract][Full Text] [Related]
13. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer.
Kim EY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM
J Thorac Oncol; 2015 Dec; 10(12):1795-9. PubMed ID: 26484630
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma.
Fukushima H; Yokoyama M; Nakanishi Y; Tobisu K; Koga F
PLoS One; 2015; 10(1):e0115895. PubMed ID: 25612215
[TBL] [Abstract][Full Text] [Related]
16. The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.
de Jong C; Chargi N; Herder GJM; van Haarlem SWA; van der Meer F; van Lindert ASR; Ten Heuvel A; Brouwer J; de Jong PA; Devriese LA; Huitema ADR; Egberts TCG; de Bree R; Deneer VHM
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1554-1564. PubMed ID: 35301821
[TBL] [Abstract][Full Text] [Related]
17. Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
Antoun S; Morel H; Souquet PJ; Surmont V; Planchard D; Bonnetain F; Foucher P; Egenod T; Krakowski I; Gaudin H; Debieuvre D
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):782-793. PubMed ID: 30932365
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Computed Tomography-Determined Sarcopenia and Postoperative Outcome After Surgery for Non-Small Cell Lung Cancer.
Kim EY; Lee HY; Kim KW; Lee JI; Kim YS; Choi WJ; Kim JH
Scand J Surg; 2018 Sep; 107(3):244-251. PubMed ID: 29284364
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
[TBL] [Abstract][Full Text] [Related]
20. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
